US 8481551
Gyrase and topoisomerase IV inhibitors
granted A61PA61P1/00A61P1/02
Quick answer
US patent 8481551 (Gyrase and topoisomerase IV inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P11/00, A61P13/02